Table 3

Parameters	Group	28 Days
Hb (g/dl)	I	14.22 ± 0.158^a
	II	13.87 ± 0.344^a
	III	12.41 ± 0.191^b
	IV	10.44 ± 0.260^c
PCV (%)	I	43.66 ± 0.279^a
	II	42.36 ± 0.352^b
	III	41.13 ± 0.285^c
	IV	34.85 ± 0.190^d
TEC (millions/cumm)	I	10.16 ± 0.205^a
	II	9.31 ± 0.247^b
	III	4.54 ± 0.341^c
	IV	3.81 ± 0.238^c
TLC (thousand/cumm)	I	9.51 ± 0.229^a
	II	8.84 ± 0.215^b
	III	7.08 ± 0.136^c
	IV	4.30 ±0.143^d
MCV (fl)	I	87.30 ± 0.337^d
	II	89.29 ± 0.296^c
	III	93.06 ± 0.201^a
	IV	91.94 ± 0.263^b
MCHC (g/dl)	I	33.12 ± 0.140^a
	II	28.83 ± 0.181^c
	III	30.57 ± 0.133^b
	IV	30.54 ± 0.291^b
MCH (pg)	I	23.53 ± 0.178^c
	II	24.52 ± 0.292^b
	III	28.58 ± 0.162^a
	IV	28.04 ± 0.153^a

Values bearing different superscripts in a column differed significantly (P ≤ 0.01), Values were expressed as mean ± SE, n=5

Table 3: Effect of acetamiprid on hematological profile in mice after daily oral administration for 28 days.